As new hardware and software are introduced into interventional suites, imaging labs and surgical theaters, who bears responsibility for bringing medical personnel up to speed on the advantages they could deliver for safety and efficacy?
Even though the Hospital Readmission Reduction Program (HRRP) targeted principal heart failure admissions, a new analysis in the Journal of the American College of Cardiology showed readmissions also declined for patients with a secondary diagnosis of heart failure.
Tracking patients’ changes in fractional flow reserve (FFR) from before to after a percutaneous coronary intervention (PCI) may provide useful information, according to new research published in JAMA Cardiology. Individuals with the greatest change in FFR were less likely to experience vessel-related events and demonstrated greater symptomatic relief.
CHICAGO, March 7, 2019 — Northwestern Medicine Bluhm Cardiovascular Institute is pioneering the use of artificial intelligence (AI) for cardiac screening in a new study of Eko’s cardiac monitoring platform. The study aims to demonstrate that Eko’s digital stethoscopes and AI algorithms can interpret heart sounds accurately to help screen for pathologic heart murmurs and valvular heart disease.
Tom Giangiulio Jr. and his wife, Carin, celebrate his 58th birthday on June 6, 2017, two weeks before Giangiulio received a transplant with a Hepatitis C-infected heart.
By the time three transplant physicians approached Tom Giangiulio Jr. about being the first patient in a new clinical trial to accept a heart from a Hepatitis C-positive donor, Giangiulio didn’t have much of a choice.
I don’t need to tell you that social determinants of health (SDoH) present challenges for your patients. You’ve seen the data indicating that as much as 80 percent of an individual’s health comes from factors other than the clinical care he or she receives. You know the impact of disparities.
Patients who remain in the hospital for longer than three days following transcatheter aortic valve replacement (TAVR) are at a 45 percent increased risk of death within one year versus those discharged sooner after the procedure, a new analysis found.
The Early Bird Bleed Monitoring System, which can detect internal bleeding during endovascular procedures, has been granted de novo classification by the FDA. The approval was announced March 5 by Saranas, the device’s manufacturer.
Following the news that FDA Commissioner Scott Gottlieb, MD, plans to resign in about a month, the American Heart Association released a statement applauding Gottlieb’s efforts to curb the e-cigarette epidemic among the country’s youth.
The International Contrast Ultrasound Society (ICUS) is again urging the FDA to remove the “black box” warning from ultrasound contrast agent (UCA) labels, following its filing of a September 2018 citizen petition with the federal agency.
